A profit-enhancing policy trumps public safety & scientific integrity In the mid-1980s, the U.S. executive branch was persuaded that the biotechnology industry would boost the U.S. economy out of its doldrums. To accommodate this newly developing industry, the executive branch gave the . . . Continue reading →
A book review by AHRP board member, John J Noble Jr, Emeritus Professor, was recently published in the Indian Journal of Medical Ethics. The book, Reducing Adverse Events in Older Patients Taking Newly Released Drugs by Margaret T. Whitstock, an Australian research professional, . . . Continue reading →
The efforts of AHRP to hold the medical research community and government administrators accountable for unethical exploitation of vulnerable children in medical experiments conducted in violation of federal regulations. Continue reading →
Scientists and entrepreneurs have tried for years to develop a safe and universal blood substitute that did not spoil after 42 days. However, all such efforts have encountered serious safety problems.
Continue reading →
December, 1990: FDA issued a waiver from informed consent to permit the Department of Defense to use unapproved, experimental drugs and vaccines – e.g. anthrax vaccine on soldiers. This violated the foremost “absolutely essential” mandatory ethical principle defined by the Nuremberg Code . . . Continue reading →
I am here in vigorous opposition to SF 2841 that would implement mental health screening for three-year-old children entering public school. Continue reading →
Nora Coffey is a prominent women’s health advocate, activist and educator who founded the Hysterectomy Educational Resources and Services (HERS) Foundation in 1982. The foundation is the only independent nonprofit organization solely dedicated to the alternatives to and aftermath of hysterectomy. In . . . Continue reading →
Bernice Eddy, PhD (1903–1989) a virologist and epidemiologist at NIH, identified SV40, a cancer-causing monkey virus that millions of children were exposed to from contaminated polio vaccines. In 1954, while the NIH was testing the first commercial polio vaccines, Eddy’s job was . . . Continue reading →
Curt D. Furberg, MD, an internationally recognized cardiovascular epidemiologist with expertise in clinical trials, drug safety and public health. Dr. Furberg is a Professor Emeritus of Public Health Sciences at Wake Forest University who has chaired NIH’s Antihypertensive and Lipid-Lowering Treatment to . . . Continue reading →
David Graham, MD, FDA’s Associate Director of Science and Medicine who, throughout his career, has been a thorn for FDA managers by identifying hazardous drug effects. In 1999, his data helped identify the risk of liver damage from Pfizer’s diabetes drug Rezulin . . . Continue reading →
Frances Oldham Kelsey MD, PhD, has earned her place as “America’s Greatest Living Heroine” — she turned 100 on July 24, 2014. Dr. Kelsey was the medical pharmacologist at the FDA who refused to license thalidomide for the U.S. market despite the . . . Continue reading →
John Anthony Morris, MD, Former Bacteriologist, Division of Biologics Standards, and Research Virologist, FDA, and prior to that he was a virologist at NIH from 1940s to 1976 when he was fired for blowing the whistle on the ineffectiveness and hazards of . . . Continue reading →
